Primary navigation

    Inhaled Corticosteroids

    Drug - Inhaled Corticosteroids

    June 2019

    Therapeutic area - Respiratory/Asthma

    Drugs

    Preferred
    Asmanex (twisthaler)
    Budesonide respules
    Flovent Diskus
    Flovent HFA
    Pulmicort Flexhaler

    Nonpreferred
    Alvesco
    Armonair Respiclick
    Arnuity Ellipta
    Asmanex HFA
    Pulmicort Respules
    QVAR Redihaler

    Approval criteria for nonpreferred products

    • Patient has a diagnosis of asthma AND
    • Patient had an adequate adherent trial and failure of (or contraindication to) 3 of the preferred products. Trials must be at least two weeks in duration of continuous daily use.

    Note: Failure is defined as no improvement or worsening in asthma symptoms after at least two weeks of continued daily use of the inhaled corticosteroid.

    Expected side effects of any agent within the class are not considered failure. Expected side effects include: 

    • bad taste
    • dysphonia
    • oropharyngeal candidiasis
    • cough
    • sore throat

    Exceptions
    See Grandfathering Criteria for patient-specific exceptions.

    Quantity limit

    One inhaler per month

    Questions?

    MHCP Provider Call Center 651-431-2700 or 800-366-5411

    back to top